1-(3-Chlorophenyl)piperazine (mCPP) - A new designer drug that is still a legal substance;1-(3-Chlorofenylo)piperazyna (mCPP) - Nowy narkotyk syntetyczny bȩda̧cy wcia̧ż legalna̧ substancja̧

Problems of Forensic Sciences

Volumn 66, Issue , 2006, Pages 220-228

  Stanaszek, Roman ^a   Zuba, Dariusz ^a  

^a INSTITUTE OF FORENSIC RESEARCH   (Poland)

Author keywords

Designer drugs; HPLC; mCPP

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; AMPHETAMINE; METOCLOPRAMIDE;

CONFERENCE PAPER; DRUG DEPENDENCE; DRUG DETERMINATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMERISM; MASS SPECTROMETRY; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY FLUORESCENCE;

EID: 34250359113     PISSN: 12307483     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Piccard G. E., Rea M. A., TFMPP, a 5HT1B receptor agonist, inhibits light-induced phase shift of the circadian activity rhythm and c-fos expression in the mouse suprachiasmatic nucleus, Neuroscience Letters 1977, 231, 95-98.
2. Wikstrom M., Holmgren P., Ahlner J., A2 (N-Benzyl-piperazine) a new drug of abuse in Sweden, Journal of Analytical Toxicology 2004, 28, 67-70.
3. Szukalski B., Pochodne piperazyny, pirolidyny, benzimidazolu i tryptaminy - nowe narkotyki zmodyfikowane, Problemy Kryminalistyki 2005, 249, 9-15.
4. Fiorella D., Helsley S., Rabin R. A. [et al.], 5-HT2C receptor-mediated phosphoinositide turnover and stimulus effects of m-chlorophenylpiperazine, Psychopharmacology 1995, 122, 237-243.
5. de Boer D., Bosman I., Hidvegi E. [et al.], Piperazine-like compounds: a new group of designer drug-of-abuse on the European market, Forensic Science International 2001, 121, 47-56.
6. Murphy D. L., Lesch K. P., Aulach C. S. [et al.], Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature and cardiovascular effects in humans, Pharmacological Reviews 1991, 43, 527-552.
7. Tencer M. E., Johnson C. E., The subjective effects of MDMA and mCPP in moderate MDMA users, Drug and Alcohol Dependence 2001, 65, 97-101.